• Increased serum levels of YKL-40 in patients with inflammatory bowel disease 

      Koutroubakis, I. E.; Petinaki, E.; Dimoulios, P.; Vardas, E.; Roussomoustakaki, M.; Maniatis, A. N.; Kouroumalis, E. A. (2003)
      Background and aims: Initiation of a fibrotic process has been suggested as part of the intestinal response to chronic inflammation in inflammatory bowel disease. YKL-40 has been proposed as a new serum marker of fibrosis. ...
    • Serum laminin and collagen IV in inflammatory bowel disease 

      Koutroubakis, I. E.; Petinaki, E.; Dimoulios, P.; Vardas, E.; Roussomoustakaki, M.; Maniatis, A. N.; Kouroumalis, E. A. (2003)
      Background/Aims: Laminin and collagen IV have been proposed as extracellular matrix serum markers. Because fibrosis is a major complication of inflammatory bowel disease, serum concentrations of laminin and collagen IV ...